363 research outputs found
The Gaia-ESO Survey: Chromospheric Emission, Accretion Properties, and Rotation in Velorum and Chamaeleon I
We use the fundamental parameters delivered by the GES consortium in the
first internal data release to select the members of Vel and Cha I
among the UVES and GIRAFFE spectroscopic observations. A total of 140
Vel members and 74 Cha I members were studied. We calculated stellar
luminosities through spectral energy distributions, while stellar masses were
derived by comparison with evolutionary tracks. The spectral subtraction of
low-activity and slowly rotating templates, which are rotationally broadened to
match the of the targets, enabled us to measure the equivalent widths
(EWs) and the fluxes in the H and H lines. The H line
was also used for identifying accreting objects and for evaluating the mass
accretion rate (). The distribution of for the
members of Vel displays a peak at about 10 km s with a tail
toward faster rotators. There is also some indication of a different
distribution for the members of its two kinematical populations. Only a handful
of stars in Vel display signatures of accretion, while many more
accretors were detected in the younger Cha~I. Accreting and active stars occupy
two different regions in a -flux diagram and we propose a
criterion for distinguishing them. We derive in the ranges
-yr and -yr
for Vel and Cha I accretors, respectively. We find less scatter in the
relation derived through the H EWs, when
compared to the H diagnostics, in agreement with other authors
Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: The ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology
The debris disk host star HD 61005: a member of the Argus Association?
HD 61005 is a nearby young solar type star that shows a large infrared excess
due to a debris disk. The disk has been recently imaged from ground and space,
with indications of several components. Some characteristics of the disk
suggest the presence of planetary companions around the star, that remain
undetected in deep adaptive optics imaging. For a better understanding of the
system we aim to refine the determination of the stellar parameters, with
emphasis on the stellar age and system orientation. We used ASAS and Hipparcos
photometry and FEROS spectra to determine the rotation period, radial and
rotational velocity, chromospheric emission, effective temperature, and
chemical composition. We find no indication of any misalignment between the
star rotation axis and the disk. The standard age calibrations applied to
several indicators yield an age close to that of the Pleiades (120 Myr);
however the kinematic properties strongly support its membership in the younger
(40 Myr) Argus association, which also includes the IC 2391 open cluster.
Detailed comparison of the properties of HD 61005 and IC 2391 members shows
that the characteristics of HD 61005 are compatible with membership to the
Argus association, once its rather slow rotation is taken into account, because
lithium and other age indicators are somewhat correlated with stellar rotation
at a fixed age. We also identify systematic differences between the field and
cluster population of the Argus association, which are probably selection
effects, so we suggest that additional members with slower rotation and lower
activity level are waiting to be identified.Comment: A&A, in press, 13 pages, 11 figure
Evolution of Human Memory B Cells From Childhood to Old Age
High quality medical assistance and preventive strategies, including pursuing a healthy lifestyle, result in a progressively growing percentage of older people. The population and workforce is aging in all countries of the world. It is widely recognized that older individuals show an increased susceptibility to infections and a reduced response to vaccination suggesting that the aged immune system is less able to react and consequently protect the organism. The SARS-CoV-2 pandemic is dramatically showing us that the organism reacts to novel pathogens in an age-dependent manner. The decline of the immune system observed in aging remains unclear. We aimed to understand the role of B cells. We analyzed peripheral blood from children (4-18 years); young people (23-60 years) and elderly people (65-91 years) by flow cytometry. We also measured antibody secretion by ELISA following a T-independent stimulation. Here we show that the elderly have a significant reduction of CD27dull memory B cells, a population that bridges innate and adaptive immune functions. In older people, memory B cells are mostly high specialized antigen-selected CD27bright. Moreover, after in vitro stimulation with CpG, B cells from older individuals produced significantly fewer IgM and IgA antibodies compared to younger individuals. Aging is a complex process characterized by a functional decline in multiple physiological systems. The immune system of older people is well equipped to react to often encountered antigens but has a low ability to respond to new pathogens
Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workers
Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: Patient level meta-analysis
Objectives: To examine the safety and effectiveness of cobalt-chromium everolimus eluting stents compared with bare metal stents.Design: Individual patient data meta-analysis of randomised controlled trials. Cox proportional regression models stratified by trial, containing random effects, were used to assess the impact of stent type on outcomes. Hazard ratios with 95% confidence interval for outcomes were reported.Data sources and study selection: Medline, Embase, the Cochrane Central Register of Controlled Trials. Randomised controlled trials that compared cobalt-chromium everolimus eluting stents with bare metal stents were selected. The principal investigators whose trials met the inclusion criteria provided data for individual patients.Primary outcomes: The primary outcome was cardiac mortality. Secondary endpoints were myocardial infarction, definite stent thrombosis, definite or probable stent thrombosis, target vessel revascularisation, and all cause death.Results: The search yielded five randomised controlled trials, comprising 4896 participants. Compared with patients receiving bare metal stents, participants receiving cobalt-chromium everolimus eluting stents had a significant reduction of cardiac mortality (hazard ratio 0.67, 95% confidence interval 0.49 to 0.91; P=0.01), myocardial infarction (0.71, 0.55 to 0.92; P=0.01), definite stent thrombosis (0.41, 0.22 to 0.76; P=0.005), definite or probable stent thrombosis (0.48, 0.31 to 0.73; P<0.001), and target vessel revascularisation (0.29, 0.20 to 0.41; P<0.001) at a median follow-up of 720 days. There was no significant difference in all cause death between groups (0.83, 0.65 to 1.06; P=0.14). Findings remained unchanged at multivariable regression after adjustment for the acuity of clinical syndrome (for instance, acute coronary syndrome v stable coro
Morphological and functional evaluation of the bioresorption of the bioresorbable everolimus-eluting vascular scaffold using IVUS, echogenicity and vasomotion testing at two year follow-up: a patient level insight into the ABSORB A clinical trial
The aim of this study was to describe vaso-reactivity (by Acetylcholine and Methergine tests) at 2 year follow-up in parallel with the individual changes in the echogenicity characteristics of the polymer struts of the everolimus eluting bioresorbable vascular scaffold (BVS), from post-treatment to 2 year follow-up, in patients enrolled in the ABSORB Cohort A study. Intravascular ultrasound assessment was performed with a phased array catheter (EagleEye, Volcano Corporation, Cordova, CA, USA) with automated pullback at 0.5 mm per second. The % ratio at 6 months and 2 years [(Scaffold Area post PCI- Lumen Area)/Scaffold Area post PCI] was calculated as a measure of scaffold shrinkage. The % change of hyperechogenicity was defined as: ([post-procedural hyperechogenicity] - [2 year follow up hyperechogenicity])/[post-procedural hyperechogenicity]) × 100. The vasomotion test with intracoronary acetylcholine (10-6M) or intravenous methergine (0.4 mg) was performed at 2 years. Overall nine patients received all these analyses and were enrolled in the present analysis. A 50-96% reduction in hyperechogenicity was observed between baseline and 2 years, which corresponded to a change in vasoreactivity between 2 and 22%. A vasoconstriction of the scaffolded segment was observed in the 5 patients, who underwent the methergine test, with a mean decrease in lumen diameter after met
Results of the NaCo Large Program: probing the occurrence of exoplanets and brown dwarfs at wide orbit
Over the past decade, a growing number of deep imaging surveys have started to provide meaningful constraints on the population of extrasolar giant planets at large orbital separation. Primary targets for these surveys have been carefully selected based on their age, distance and spectral type, and often on their membership to young nearby associations where all stars share common kinematics, photometric and spectroscopic properties. The next step is a wider statistical analysis of the frequency and properties of low mass companions as a function of stellar mass and orbital separation. In late 2009, we initiated a coordinated European Large Program using angular differential imaging in the H band (1.66 μm) with NaCo at the VLT. Our aim is to provide a comprehensive and statistically significant study of the occurrence of extrasolar giant planets and brown dwarfs at large (5-500 AU) orbital separation around ~150 young, nearby stars, a large fraction of which have never been observed at very deep contrast. The survey has now been completed and we present the data analysis and detection limits for the observed sample, for which we reach the planetary-mass domain at separations of ≳50 AU on average. We also present the results of the statistical analysis that has been performed over the 75 targets newly observed at high-contrast. We discuss the details of the statistical analysis and the physical constraints that our survey provides for the frequency and formation scenario of planetary mass companions at large separatio
Highly specific memory b cells generation after the 2nd dose of bnt162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal iga
Specific memory B cells and antibodies are a reliable read-out of vaccine efficacy. We analysed these biomarkers after one and two doses of BNT162b2 vaccine. The second dose significantly increases the level of highly specific memory B cells and antibodies. Two months after the second dose, specific antibody levels decline, but highly specific memory B cells continue to increase, thus predicting a sustained protection from COVID-19. We show that although mucosal IgA is not induced by the vaccination, memory B cells migrate in response to inflammation and secrete IgA at mucosal sites. We show that the first vaccine dose may lead to an insufficient number of highly specific memory B cells and low concentration of serum antibodies, thus leaving vaccinees without the immune robustness needed to ensure viral elimination and herd immunity. We also clarify that the reduction of serum antibodies does not diminish the force and duration of the immune protection induced by vaccination. The vaccine does not induce sterilizing immunity. Infection after vaccination may be caused by the lack of local preventive immunity because of the absence of mucosal IgA
- …